GB1509979A — Pharmaceutical compositions containing aspirin or indomethacin
Assigned to Fisons Ltd · Expires 1978-05-10 · 48y expired
What this patent protects
1509979 Aspirin and indomethacin compositions, multilayer tablet FISONS Ltd 15 Nov 1976 [28 Nov 1975] 48935/75 Heading A5B Gastrointestinal side - effects of aspirin and indomethacin can be reduced by administering the drugs in combination with 1, 3 - bis (2 - carboxychromon - 5 …
USPTO Abstract
1509979 Aspirin and indomethacin compositions, multilayer tablet FISONS Ltd 15 Nov 1976 [28 Nov 1975] 48935/75 Heading A5B Gastrointestinal side - effects of aspirin and indomethacin can be reduced by administering the drugs in combination with 1, 3 - bis (2 - carboxychromon - 5 - yloxy) propan - 2- ol or a salt thereof, e.g. disodium cromoglycate. In example 4 a two or three layer tablet comprises aspirin in the core and sodium cromoglycate in the outermost layer.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.